HomeHealth articlesdementiaWhat Is Binswanger's Disease?

Binswanger’s Disease - Causes, Symptoms, Diagnosis, and Treatment

Verified dataVerified data
0
Binswanger’s Disease - Causes, Symptoms, Diagnosis, and Treatment

4 min read

Share

Binswanger's disease, which is also known as subcortical vascular dementia, is a distinctive form of dementia. To discover more about the condition, keep reading the article.

Written by

Dr. Shikha

Medically reviewed by

Dr. Abhishek Juneja

Published At July 27, 2022
Reviewed AtAugust 30, 2022

What Is Binswanger's Disease?

Binswanger's disease, also known as subcortical vascular dementia, is a kind of dementia caused by widespread, tiny regions of white matter damage in the brain's deep layers. The damage is caused by the thickening and constriction (atherosclerosis) of the arteries that supply the subcortical region of the brain. Atherosclerosis (also known as "artery stiffening") is a systemic disease that affects blood vessels all over the body.

The build-up of lipids, cholesterol, and other elements in and on the walls of your arteries is known as atherosclerosis. Plaque is the term used for this accumulation of fat and lipids. The arteries may narrow as a result of the plaque, thereby interfering with the blood flow. A blood clot can happen if the plaque bursts. It starts late in life, in the fourth decade, and gets worse as you get older. The blood supply to the brain tissue reduces as the arteries narrow, and this ultimately leads to the death of brain tissue.

What Is the Cause of Binswanger's Disease?

Binswanger's disease is a condition that affects people suffering from thromboembolism, where a blood clot that forms in an artery breaks away, travels through the bloodstream and stops another blood vessel; arteriosclerosis is a condition in which thickening, stiffening, and loss of flexibility of artery walls occur and other diseases that impede blood flow to the brain's deep areas. Binswanger disease is caused by hypertension, smoking, hypercholesterolemia, cardiac disease, and diabetes mellitus.

Binswanger's illness can also be caused by rare genetic diseases like CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). CADASIL is a rare genetic condition that affects the small blood vessels present in the brain. CADASIL is a word that was originally coined in 1993. Even among members of the same family, the age of onset, intensity, particular symptoms, and illness course differ significantly.

CADASIL is an acronym that stands for the following words: (C) cerebral - having to do with the brain, (A) autosomal, (D) dominant– a type of inheritance in which only one copy of a defective gene is required for the disorder to manifest, (A) arteriopathy is an artery disease (blood vessels which carry blood away from the heart), specific parts of the brain nourished by deep tiny blood veins are referred to be (S) subcortical, (I) infarcts - brain tissue loss caused by a lack of blood flow to the brain, which happens when circulation through the tiny arteries is substantially diminished or interrupted, (L) leukoencephalopathy, which are lesions present in the white matter of the brain denoting the presence of the disease and gets reflected in a magnetic resonance imaging (MRI).

Binswanger disease, then, is a clinical syndrome of vascular dementia caused by a variety of factors rather than a single disease. Reduced blood flow in the brain tissue appears to cause secondary inflammation, which could be a target for therapy.

What Are the Symptoms and Signs of Binswanger's Disease?

Patients with Binswanger's disease frequently suffer from varying levels of cognitive impairment. People who have been affected are frequently unhappy, indifferent (uncaring), lazy, and incapable of acting or making decisions (abulic). They withdraw, make poor decisions, lack planning and organizational abilities, and communicate less naturally. Upper motor symptoms, asymmetric hyperreflexia, and moderate parkinsonism are common on physical examination. Dysarthria (difficulty speaking), dysphagia (difficulty swallowing), and urinary bladder control may also be problems for those who are affected (incontinence).

Some patients have symptoms comparable to Parkinson's disease, such as inadequate balance, slowness, and shuffling short steps (parkinsonism). Tremor is a rather uncommon symptom. Many persons with Binswanger disorder have previously experienced transient ischemic attacks or strokes. The signs and symptoms of this ailment, in contrast to being steadily progressive like the course of other neurodegenerative disorders, emerge in a stepwise or a stuttering pattern.

How Is Binswanger's Disease Diagnosed?

The diagnosis of Binswanger's disease can be difficult at first, but as the clinical course is learned, the diagnosis becomes more apparent. White matter hyperintensities, for example, are discovered by chance while examining the brains of healthy people. These individuals are self-sufficient, and no impairments may be detected during an office visit. Similar population studies with in-depth neuropsychological evaluations, on the other hand, have found a link between white matter hyperintensities and mild cognitive impairment. In population-level investigations, white matter hyperintensities were also linked to an increased risk of intracerebral hemorrhage and ischemic stroke. White matter hyperintensities in the subclinical stage linked to hypertension could be a precursor to Binswanger's disease.

A comprehensive clinical evaluation that includes a full medical history of the patient, physical examination, and computerized tomography (CT) or magnetic resonance imaging (MRI) scans of the brain is commonly used to diagnose Binswanger's illness. In the deep structures of the brain, magnetic resonance imaging (MRI) and computerized tomography (CT) scans demonstrate nerve fiber (white matter) deterioration and many minor strokes.

What Is the Treatment for Binswanger's Disease?

Considering that Binswanger disease's ischemic brain damage is permanent, treatment focuses on reducing factors that can cause stroke and, therefore, slowing the disease's progression. Symptomatic treatment is used. Antidepressant drugs such as Sertraline or Citalopram, which are serotonin-specific reuptake inhibitors (SSRIs), may be necessary for people suffering from depression or anxiety. Atypical antipsychotic drugs like Olanzapine and Risperidone can help persons with hyperactivity and disruptive behavior. Treatments include blood pressure medications, antiplatelet medicines including Warfarin or Aspirin to avoid thromboembolism, Statins to avoid atherosclerosis, cessation of smoking, and diabetes management. For treating depression generated due to Binswanger disease, antidepressant drugs are helpful. The only other option is symptomatic and supportive treatment.

Dr. Binswanger: Who Was He?

Dr. Otto Binswanger was born in Switzerland on October 14, 1852, and died on July 15, 1929. Binswanger went on to become a doctor and spent several years as the director of a mental institution. He described a disorder he dubbed "encephalitis subcorticalis chronica progressiva" in 1894, which became known as Binswanger's disease later.

Conclusion:

Binswanger's disease is a chronic illness, and changes can be immediate or gradual, usually progressing in stages. Binswanger's disease and Alzheimer's disease frequently coexist. This disease can be slowed by behaviors that delay the onset of high blood pressure, diabetes, and atherosclerosis, such as eating a balanced diet and following a healthy wake or sleep schedule, regular exercising, and not smoking or drinking alcohol.​

Frequently Asked Questions

1.

What Is the Outlook for Binswanger's Disease?

Binswanger's disease is a type of vascular dementia that occurs due to damage to the small blood vessels in the brain. Unfortunately, the cure is unknown for this disease, and its prognosis is generally poor. The progression of the disease can lead to significant disability and eventually death, with many patients experiencing a decline in cognitive function and mobility. Treatment focuses on managing symptoms and addressing underlying conditions that may contribute to the development of the disease.

2.

Is There a Remedy for Binswanger's Disease?

Currently, there is no known cure for Binswanger's disease. Treatment is done to manage symptoms and improve the patient's quality of life. This may involve medication to control blood pressure, cholesterol, and other risk factors for the disease, as well as physical and occupational therapy to help maintain mobility and independence. Counseling and support groups may also help patients and their families cope with this condition's challenges.

3.

What Are the Characteristics of Binswanger's Disease?

Binswanger's disease is a type of vascular dementia that affects the brain's small blood vessels. Its features include cognitive decline, difficulty with movement and balance, urinary incontinence, and depression. Patients may also experience changes in their mood, behavior, and personality. These symptoms can be progressive, leading to significant disability and reduced quality of life. Treatment focuses on managing symptoms and addressing underlying conditions that may contribute to the development of the disease.

4.

At What Age Does Binswanger's Disease Typically Begin?

Binswanger's disease typically begins in individuals over 60, although it can occur in younger people. The disease is more common in high blood pressure individuals with cardiovascular risk factors. Women may also be at higher risk for the disease than men. The symptoms of the disease can be progressive, leading to significant disability and reduced quality of life. Treatment focuses on managing symptoms and addressing underlying conditions that may contribute to the development of the disease.

5.

What Is the Maximum Life Expectancy for Someone with Vascular Dementia?

The maximum life expectancy for someone with vascular dementia can vary depending on factors such as the disease's severity, the individual's age, and any underlying health conditions they may have. On average, individuals with vascular dementia have a shorter life expectancy than those without the disease. In many cases, the disease can lead to a decline in cognitive function and mobility and an increased risk of stroke and other cardiovascular events.

6.

Who Is Binswanger, and What Is Their Significance in the Context of This Disease?

Binswanger's disease is named after Otto Binswanger, a Swiss physician who first described the disease in the late 19th century. Binswanger's disease is called subcortical vascular dementia or small vessel dementia. The disease is characterized by damage to the small blood vessels in the brain, leading to cognitive decline and other neurological symptoms. Although Binswanger was the first to describe the disease, many medical professionals have studied and researched it extensively.

7.

What Changes Occur in the Brain with Vascular Dementia?

Vascular dementia, including Binswanger's disease, is caused by damage to the brain's blood vessels, which decline in cognitive function and other neurological symptoms. Various factors, such as high blood pressure, raised cholesterol, smoking, and other cardiovascular risk factors, can cause this damage. As the disease progresses, the brain tissue can become increasingly damaged, leading to more severe symptoms. Treatment focuses on managing symptoms and addressing underlying conditions that may contribute to the development of the disease.

8.

What Is the Final Stage of Dementia?

The last stage of dementia is typically characterized by severe cognitive decline and a loss of physical function. Patients in this stage may have difficulty communicating and may require assistance with all aspects of daily living, including eating, bathing, and toileting. They may also be at increased risk of infections and other medical complications. This stage can be challenging for patients and their families, and treatment focuses on managing symptoms and providing supportive care. Hospice care may be appropriate for patients in this stage to provide comfort and improve their quality of life.

9.

What Are the End-of-Life Stages of Dementia?

The final stages of dementia before death depend upon the individual and the type of dementia they have. Generally, patients in the final stages of dementia may have difficulty communicating, be bedridden, and have difficulty eating and drinking. They may also experience changes in breathing and heart rate. As the disease progresses, patients may become increasingly unresponsive and eventually slip into a coma. Treatment is done to manage symptoms and provide supportive care to improve the patient's and their family's quality of life.

10.

Do People with Dementia Tend to Sleep More?

Dementia patients may experience changes in their sleep patterns, including sleeping more during the day and having difficulty sleeping at night. This can be caused by changes in the brain that affect the sleep-wake cycle, as well as underlying medical conditions and medications. Maintaining good sleep hygiene and addressing any underlying medical conditions contributing to changes in sleep patterns is essential.

11.

How Can One Prevent Dementia?

There is no known definite way to prevent dementia completely, there are steps individuals can take to reduce their risk. This includes engaging in regular exercise, maintaining a healthy diet, managing underlying medical conditions such as high blood pressure and diabetes, and staying socially and mentally active. It is also important to avoid tobacco and excessive alcohol use. Additionally, some studies have suggested that cognitive training and brain exercises may help reduce the risk of dementia in older adults.

12.

What Is the Ultimate Cause of Death in Dementia?

The final cause of death in individuals with dementia can vary depending on factors such as the type and severity of the disease and underlying health conditions. However, common causes of death in dementia patients include pneumonia and urinary tract infections, as well as complications from falls and other injuries. Patients may become increasingly vulnerable to these and other medical complications as the disease progresses.

13.

What Is the Most Effective Treatment for Vascular Dementia?

Treatment for vascular dementia, including Binswanger's disease, focuses on managing symptoms and addressing the underlying cause of the disease. This may include medications for high blood pressure, high cholesterol, and other cardiovascular risk factors. Additionally, healthcare providers may recommend cognitive and behavioral therapies to help manage symptoms such as memory loss and changes in behavior. In some cases, medications such as cholinesterase inhibitors may be used to improve cognitive function in patients with mild to moderate dementia.

14.

Can Vascular Dementia Lead to Death?

Vascular dementia, including Binswanger's disease, can be a progressive and debilitating condition contributing to a shortened life expectancy. While patients may live for several years with the disease, the prognosis can vary depending on factors such as the severity of symptoms and underlying medical conditions. Additionally, patients may be at increased risk of complications, including infections and falls, which can contribute to a shortened life expectancy.

15.

At What Point Do Dementia Patients Typically Start Forgetting Their Loved Ones?

As dementia progresses, patients may experience changes in memory and cognitive function, including forgetting family members and loved ones. This can be distressing for both the patient and their family members. However, the timing and severity of these changes can vary depending on the individual and the type of dementia they have. In some cases, patients may remember family members and loved ones until the later stages of the disease, while in others, memory loss may occur earlier.

16.

What Is the Most Frequent Cause of Death in Individuals with Dementia?

The most common cause of death in dementia patients is complications from medical conditions such as infections, falls, Patientsprogresses, patients may become increasingly vulnerable to these and other m as the disease progressesedical complications. Additionally, some studies have suggested that patients with dementia may be at increased risk of cardiovascular disease and other chronic medical conditions.

17.

Why Do Dementia Patients Often Lose Their Appetite?

Dementia patients may stop eating due to various factors, including changes in appetite, difficulty swallowing, and other medical complications. Additionally, as the disease progresses, patients may experience changes in mood and behavior that can affect their willingness to eat. This can lead to malnutrition and other medical complications, further exacerbating the patient's condition.

18.

What Is the Primary Cause of Dementia?

The most common cause of dementia is Alzheimer's, accounting for approximately 60-80% of all cases. Alzheimer's disease is a progressive condition characterized by the accumulation of abnormal protein deposits in the brain, which can lead to cognitive decline and memory loss. Other common causes of dementia include vascular dementia, Lewy body dementia, and frontotemporal dementia.
Dr. Abhishek Juneja
Dr. Abhishek Juneja

Neurology

Tags:

dementia
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

dementia

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy